Search

everythinglearnresearchcommunity

for

Search:↓

A patient with a severe type of hair loss experienced partial hair regrowth after treatment with a specific light therapy and a medication called interferon α2a.

Certain gene variations may increase the risk and severity of alopecia areata.

Leflunomide is more likely to help treat alopecia areata than cause it.

Imiquimod improved skin pigmentation in most patients with xeroderma pigmentosum and may prevent further skin cancer, but some treatments can have side effects.

The health of the sentinel lymph node is the best indicator of survival for patients with thick skin cancer.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

SH-MSCs gel can effectively treat alopecia by increasing IL-10 and decreasing TNF-α gene expression.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

Oral ulcers are common in SLE patients and often link to other symptoms.

Dogs with dermatomyositis, especially Collies and Shetland Sheepdogs, need better treatments for their skin and muscle inflammation.

Photobiomodulation therapy may help treat hair loss in people with darker skin, but more research is needed.

Innate lymphoid cells type 1 may contribute to alopecia areata by damaging hair follicles.

Ajwain seed extract improved skin healing and hair growth in a mouse skin irritation model.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

Skin bacteria can help wound healing by activating certain immune cells.

A new TP63 mutation was found in a baby with EEC syndrome, showing the need for TREC testing to check for immune issues.

There's a growing resistance to the antibiotic mupirocin in children's skin infections caused by MRSA in New York.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

Hair and nail conditions can stabilize or improve over time, and new treatments show promise.

Lower adrenal hormone levels may cause hair loss in postmenopausal women, certain patterns help diagnose nail cancer, and a gene variant linked to higher skin cancer risk in kidney transplant patients suggests monitoring folate levels.

The secretions of mesenchymal stem cells could be used for healing without using the cells themselves.

VEGF helps hair grow and determines follicle size by increasing blood vessel growth.

Stress can worsen skin and hair conditions by affecting the skin's immune response and hormone levels.

The document concludes that the understanding of scar formation is incomplete and current prevention and treatment for hypertrophic scars and keloids are not fully effective.

Some drugs can cause rare but potentially deadly skin reactions, and early treatment and avoiding the drug again are key.

The immune system plays a key role in tissue repair, affecting both healing quality and regenerative ability.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Stress stops hair growth in mice by causing early hair growth phase end and harmful inflammation through a specific nerve-related pathway.